Fund shareholders of Harvard Bioscience Inc
ISIN US4169062043 · United States · LEI 549300VLGB1D47GGC642
- Fund shareholders
- 19
- Of which ETFs
- 4 15 other funds
- Value held
- 1.5M $
- Share of capital
- 5.2 % of 4.6M shares on Aug 4, 2026
This issuer has other securities: HARVARD BIOSCIENCE INC (US4169061052)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 123,470 | 759.3K $ | 2.71 % | as of Jun 30, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 42,043 | 258.6K $ | 0.00 % | 0.92 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 27,769 | 163.3K $ | 0.00 % | 0.61 % | as of May 31, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 13,380 | 82.3K $ | 0.07 % | 0.29 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,017 | 41.3K $ | 0.15 % | as of May 31, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 5,946 | 35K $ | 0.13 % | as of May 31, 2026 ↗ | |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 4,112 | 25.3K $ | 0.09 % | as of Jun 30, 2026 ↗ | |
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 4,000 | 24.6K $ | 0.09 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,936 | 17.3K $ | 0.00 % | 0.06 % | as of May 31, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 1,902 | 11.6K $ | 0.00 % | 0.04 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 1,366 | 8.3K $ | 0.00 % | 0.03 % | as of Jul 31, 2026 ↗ |
| U.S. VECTOR EQUITY PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,229 | 7.5K $ | 0.00 % | 0.03 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 1,029 | 6.3K $ | 0.02 % | as of Jul 31, 2026 ↗ | |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 928 | 5.7K $ | 0.00 % | 0.02 % | as of Jul 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 683 | 4.2K $ | 0.00 % | 0.02 % | as of Jun 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 601 | 3.7K $ | 0.00 % | 0.01 % | as of Jun 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 258 | 1.6K $ | 0.01 % | as of Jul 31, 2026 ↗ | |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 30 | 176.4 $ | 0.00 % | as of May 29, 2026 ↗ | |
| U.S. Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 24 | 146.4 $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Gabelli Global Mini Mites Fund GAMCO Global Series Funds, Inc | 0.09 % | as of Jun 30, 2026 ↗ |
| ACUITAS US MICROCAP FUND FORUM FUNDS II | 0.07 % | as of Jun 30, 2026 ↗ |
| Dimensional US Sustainability Core 1 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 19 | +11 | 238,723 | +33.0 % |
| 2026Q2 | 8 | 179,432 |
Institutional managers
30 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| WEBER CAPITAL MANAGEMENT LLC /ADV | 320,037 | 1.6M $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 179,614 | 873 $ | as of Mar 31, 2026 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 124,810 | 607.8K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 114,117 | 555.8K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 101,427 | 493.9K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 62,226 | 303K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 59,511 | 289.9K $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 46,332 | 225.6K $ | as of Mar 31, 2026 |
| Williams & Novak, LLC | 27,052 | 137.7K $ | as of Mar 31, 2026 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 27,021 | 131.6K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 23,830 | 116.1K $ | as of Mar 31, 2026 |
| RBF Capital, LLC | 16,000 | 77.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 14,932 | 72.7K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 10,230 | 49.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,405 | 40.9K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 6,273 | 30.6K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 4,463 | 20.8K $ | as of Mar 31, 2026 |
| FMR LLC | 3,274 | 15.9K $ | as of Mar 31, 2026 |
| GROUP ONE TRADING LLC | 2,182 | 10.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,628 | 7.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 1,152 | 5.6K $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 866 | 4.2K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 855 | 4K $ | as of Mar 31, 2026 |
| Brown Shipley& Co Ltd | 478 | 2.3K $ | as of Mar 31, 2026 |
| NISA INVESTMENT ADVISORS, LLC | 228 | 1.1K $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Harvard Bioscience Inc". https://titelia.com/en/stocks/harvard-bioscience-inc-US4169062043